More on VIR
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $10.47 |
|
|||
| Open | $10.49 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $10.49 | ||||
| Day Low | $9.91 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 1,735,553 | ||||
- Form 8-K Vir Biotechnology, Inc. For: Oct 09
- Vir Biotechnology and Gilead Sciences strike solid tumor drug deal
- Vir Biotechnology Enters Multi-Program Collaboration and License Agreement with Gilead Sciences to Discover and Develop Novel PRO-XTEN® Dual-masked T-cell Engagers for Solid Tumors
- Form 8-K Vir Biotechnology, Inc. For: Oct 08
- FDA grants fast track status to Vir Biotechnology's prostate cancer drug
- Vir Biotechnology Announces PSMA-targeted PRO-XTEN® Dual-masked T-cell Engager VIR-5500 Received FDA Fast Track Designation for the Treatment of Prostate Cancer
- Vir Biotechnology (VIR) PT Raised to $22 at H.C. Wainwright
- Vir Biotechnology names David Liu as chief medical officer
- Vir Biotechnology Appoints David Liu as Chief Medical Officer
- Form 3 Vir Biotechnology, Inc. For: Oct 05 Filed by: Sawaf Aziz
Entities mentioned with VIR
- FDA | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Maynard Um | View Related Stories »
- Barron's | View Related Stories »
- Goldman Sachs | View Related Stories »
- JPMorgan | View Related Stories »
- Show More...
